We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Ameresco
AMRC
$1.34B
| $918K | ﹤0.01% |
27,482
-4,220
| -13% | -$128K |
|
2027
Theravance Biopharma
TBPH
$876M
| $918K | ﹤0.01% |
62,057
-8,800
| -12% | -$165K |
|
2028
nLIGHT
LASR
$2.88B
| $917K | ﹤0.01% |
39,075
-5,975
| -13% | -$137K |
|
2029
Progyny
PGNY
$2.18B
| $915K | ﹤0.01% |
31,092
-3,810
| -11% | -$105K |
|
2030
BioCryst Pharmaceuticals
BCRX
$2.52B
| $912K | ﹤0.01% |
265,495
-10,754
| -4% | -$46.1K |
|
2031
Beam Therapeutics
BEAM
$2.82B
| $912K | ﹤0.01% |
37,033
+22,386
| +153% | +$555K |
|
2032
Quince Therapeutics
QNCX
$30.4M
| $912K | ﹤0.01% |
91
-12
| -12% | -$109K |
|
|
ALX
2033
Alexander's
ALX
$1.38B
| $904K | ﹤0.01% |
3,685
-427
| -10% | -$108K |
|
|
UBA
2034
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $902K | ﹤0.01% |
98,097
-25,837
| -21% | -$256K |
|
2035
Future Fuel
FF
$227M
| $898K | ﹤0.01% |
79,019
-5,580
| -7% | -$69.6K |
|
2036
Gossamer Bio
GOSS
$85M
| $897K | ﹤0.01% |
72,300
-5,795
| -7% | -$76.8K |
|
|
KDMN
2037
DELISTED
Kadmon Holdings, Inc.
KDMN
| $894K | ﹤0.01% |
228,113
-27,420
| -11% | -$115K |
|
|
GOOD
2038
Gladstone Commercial Corp
GOOD
$619M
| $892K | ﹤0.01% |
52,949
-7,445
| -12% | -$136K |
|
2039
Cars.com
CARS
$654M
| $891K | ﹤0.01% |
110,228
-13,482
| -11% | -$105K |
|
2040
Federal Agricultural Mortgage
AGM
$2.54B
| $889K | ﹤0.01% |
13,959
-2,082
| -13% | -$135K |
|
2041
Golar LNG
GLNG
$5.16B
| $888K | ﹤0.01% |
146,596
-21,680
| -13% | -$194K |
|
2042
Motorcar Parts of America
MPAA
$235M
| $881K | ﹤0.01% |
56,604
-3,316
| -6% | -$56.8K |
|
|
FMTX
2043
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $879K | ﹤0.01% |
+17,633
| New | +$713K |
|
2044
Arvinas
ARVN
$589M
| $875K | ﹤0.01% |
37,077
-5,295
| -12% | -$153K |
|
|
CUTR
2045
DELISTED
Cutera, Inc.
CUTR
| $873K | ﹤0.01% |
45,999
-2,385
| -5% | -$36.8K |
|
|
XRN
2046
Chiron Real Estate Inc
XRN
$476M
| $871K | ﹤0.01% |
12,898
-2,774
| -18% | -$174K |
|
2047
Acco Brands
ACCO
$402M
| $868K | ﹤0.01% |
149,674
-19,777
| -12% | -$129K |
|
|
RAD
2048
DELISTED
Rite Aid Corporation
RAD
| $866K | ﹤0.01% |
91,252
-15,124
| -14% | -$216K |
|
2049
Inseego
INSG
$87.7M
| $864K | ﹤0.01% |
8,369
-1,353
| -14% | -$156K |
|
2050
ANI Pharmaceuticals
ANIP
$1.72B
| $859K | ﹤0.01% |
30,435
-1,363
| -4% | -$40.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.